IL17A and neoplasm: The role of IL-17 in either promoting or dampening anti-tumour immunity has been controversial with studies reporting conflicting effects of IL-17 in either promoting or inhibiting anti-tumour immunity in different solid tumour types (Vitiello and Miller 2019).